🇺🇸 FDA
Pipeline program

Suspension of autologous mononuclear cells separated from bone marrow aspirate

BMMNC_PTA_003

Phase 2 small_molecule active

Quick answer

Suspension of autologous mononuclear cells separated from bone marrow aspirate for chronic limb-threatening ischemia, diabetic foot ulcers is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
chronic limb-threatening ischemia, diabetic foot ulcers
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials